title: [Choice of Adjuvant Chemotherapy Based on Breast Cancer Subtype].
abstract: Adjuvant chemotherapy targets micrometastases. If micrometastases are destroyed, patients with breast cancer will be cured. Currently, in Japan, standard breast cancer therapy is decided based on subtypes that are defined according to ER, PgR, HER2, and Ki-67 expression. We present here an outline of the recommended chemotherapy regimens based on evidence.
authors.affiliation: Dept. of Breast Oncology, Saitama Medical University International Medical Center.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Shimada
authors.forename: Nobuko
authors.initials: N
authors.lastname: Fujiuchi
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Saeki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D006801:Humans; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor